The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Beerman Noah D since 2009.
The trader's CIK number is 1303479.
At the time of the last reporting, Beerman Noah D was the Executive Vice Presi of Fortress Biotech, Inc.. (stock ticker symbol FBIO).
Also see all insider trading activities at Fortress Biotech, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2010 | RXII | 10,000 | $22,290 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | CNDO | 5,000 | $19,400 | 0 | $0 | 0 | $0 |
2012 | CNDO | 10,000 | $49,960 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2009 | IDEV | 0 | $0 | 0 | $0 | 100,443 | $0 |
1. Sellas Life Sciences Group, Inc. (RXII)
2. Fortress Biotech, Inc. (CNDO)
3. Indevus Pharmaceuticals Inc (IDEV)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2010-07-09 | RXII | Buy | 10,000 | 2.23 | 22,290 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-05-31 | CNDO | Buy | 5,000 | 3.88 | 19,400 |
2012-06-22 | CNDO | Buy | 5,000 | 5.00 | 25,000 |
2012-01-12 | CNDO | Buy | 5,000 | 4.99 | 24,960 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-02-23 | IDEV | Option Ex | 100,443 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Beerman Noah D (Executive Vice Presi of Fortress Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.